Ray Gerald L & Associates Ltd. Has $581,000 Position in Danaher Corporation (DHR)
Ray Gerald L & Associates Ltd. maintained its position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,880 shares of the conglomerate’s stock at the close of the second quarter. Ray Gerald L & Associates Ltd.’s holdings in Danaher Corporation were worth $581,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in DHR. Peddock Capital Advisors LLC boosted its stake in Danaher Corporation by 17.4% during the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. Proficio Capital Partners LLC grew its holdings in Danaher Corporation by 92.3% during the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after buying an additional 598 shares in the last quarter. ClariVest Asset Management LLC purchased a new position in Danaher Corporation during the 1st quarter valued at approximately $157,000. Cornerstone Advisors Inc. grew its holdings in Danaher Corporation by 62.0% during the 2nd quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock valued at $178,000 after buying an additional 808 shares in the last quarter. Finally, Baystate Wealth Management LLC grew its holdings in Danaher Corporation by 11.3% during the 2nd quarter. Baystate Wealth Management LLC now owns 2,115 shares of the conglomerate’s stock valued at $181,000 after buying an additional 215 shares in the last quarter. 75.68% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now owns 155,520 shares of the company’s stock, valued at approximately $12,718,425.60. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider William King sold 7,458 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $82.97, for a total transaction of $618,790.26. Following the transaction, the insider now directly owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 over the last ninety days. Corporate insiders own 12.20% of the company’s stock.
Shares of Danaher Corporation (NYSE DHR) opened at 86.52 on Wednesday. The firm has a 50-day moving average of $84.54 and a 200 day moving average of $84.14. The company has a market cap of $60.10 billion, a P/E ratio of 27.62 and a beta of 1.03. Danaher Corporation has a 52 week low of $75.71 and a 52 week high of $88.62.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 earnings per share. Equities analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be paid a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.83%.
A number of analysts have issued reports on the company. Zacks Investment Research downgraded Danaher Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 27th. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $83.00 target price on shares of Danaher Corporation in a research report on Tuesday, September 26th. BidaskClub upgraded Danaher Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, July 19th. J P Morgan Chase & Co reissued an “overweight” rating and issued a $95.00 target price on shares of Danaher Corporation in a report on Friday, September 8th. Finally, Citigroup Inc. set a $96.00 target price on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. One analyst has rated the stock with a sell rating, four have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $91.98.
TRADEMARK VIOLATION NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/ray-gerald-l-associates-ltd-has-581000-position-in-danaher-corporation-dhr/1606759.html.
Danaher Corporation Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.